Clinical Trial Update: A Study Of Early Markers Of Choroidal Neovascularization

View source ↗

Summary

Pfizer-sponsored clinical trial investigating early markers of choroidal neovascularization in age-related macular degeneration has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Snippet

Sponsor: Pfizer | Conditions: Choroidal Neovascularization (CNV), Age-related Macular Degeneration (AMD) | Status: TERMINATED